✦ LIBER ✦

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study

✍ Scribed by Fizazi, Karim; Delva, Rémi; Caty, Armelle; Chevreau, Christine; Kerbrat, Pierre; Rolland, Frederic; Priou, Frank; Geoffrois, Lionnel; Rixe, Olivier; Beuzeboc, Philippe; Malhaire, Jean-Pierre; Culine, Stephane; Aubelle, Marie-Stephanie; Laplanche, Agnes

Book ID: 122552534
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 337 KB
Volume: 65
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2013.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8001 Randomized multicenter phase II tri

8001 Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Co-operative Oncology Group (HeCOG) study

✍ Mountzios, G.; Dimopoulos, M.A.; Bamias, A.; Vourli, G.; Kalofonos, H.; Aravanti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A multicenter phase II study of the effi

A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaı̈ve patients with metastatic or locally advanced non-small cell lung cancer

✍ James C.M. Ho; E.H. Tan; S.S. Leong; C.H. Wang; Y. Sun; R. Li; M.I.A. Wahid; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Equitoxicity of bolus and infusional eto

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

✍ Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 259 KB

1383 COMBINATION OF α-ADRENERGIC RECEPTO

1383 COMBINATION OF α-ADRENERGIC RECEPTOR BLOCKERS AND 5 α-REDUCTASE INHIBITORS FOR MODERATE TO SEVERE BENIGN PROSTATE HYPERPLASIA (BPH) PATIENTS WITH OR WITHOUT CONCOMITANT HYPERTENSION: RESULTS OF A PROSPECTIVE OBSERVATIONAL REAL-LIFE CLINICAL PRACTICE STUDY USING MULTICENTER REGISTRIES IN CHINA

✍ Sun, Ying-Hao; Xu, Chuan-Liang; Yang, Bo; Zhou, Tie 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 55 KB

The Effect of Darapladib on Plasma Lipop

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

✍ Emile R. Mohler III; Christie M. Ballantyne; Michael H. Davidson; Markolf Hanefe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Reply to Chris R. Cardwell, Samy Suissa

Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007

✍ Grytli, Helene Hartvedt; Fagerland, Morten Wang; Fosså, Sophie D.; Taskén, Krist 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 100 KB